Early detection marker for degenerative osteoarthritis with trim24-rip3 axis
AssigneeAjou University Industry-Academic Cooperation Foundation
InventorsYou-Sun KIM, Siyoung YANG
Life of this patent
Estimating the term…
Abstract
Disclosed is the novel use of TRIM24 and RIP3 as biomarkers for diagnosing osteoarthritis, in which it is first identified that TRIM24 and RIP3 can be used as biomarkers for diagnosing osteoarthritis by confirming the tendency of TRIM24 expression to decrease and RIP3 expression to increase at the onset of osteoarthritis. These two proteins are useful in confirming the change in the expression level from the onset of osteoarthritis, thus enabling early diagnosis of osteoarthritis and effectively blocking the progression of osteoarthritis at an early stage.
Claims7
-8. (canceled)
A method for diagnosing osteoarthritis comprising an agent for measuring an expression or activity level of at least one of TRIM24 and RIP3,
- wherein the agent is a primer that specifically binds to a polynucleotide encoding TRIM24 or a polynucleotide encoding RIP3,
- wherein the primer comprises the sequence of SEQ ID NO:
- 5, 19, 25 or 26.
A kit for diagnosing osteoarthritis comprising an agent for measuring an expression or activity level of at least one of TRIM24 and RIP3,
- wherein the agent is a primer that specifically binds to a polynucleotide encoding TRIM24 or a polynucleotide encoding RIP3,
- wherein the primer comprises the sequence of SEQ ID NO:
- 5, 19, 25 or 26.
A method of screening a material for preventing or treating osteoarthritis, comprising:
- (a) treating a cell with a candidate material for preventing or treating osteoarthritis;
- and
- (b) selecting a material that performs at least one of an increase in expression of TRIM24 and a decrease in expression of RIP3 in the cell as a material for preventing or treating osteoarthritis.
Dependencies are inferred from the claim text.